How to Recruit Former Regulators for Payer Research

Recruiting former regulators for payer and reimbursement research starts with defining the exact policy, coverage, coding, payment, or HTA question you need answered. From there, identify former officials whose responsibilities directly overlapped with that decision, screen their post-employment and confidentiality obligations, offer appropriate market-based compensation, and conduct a tightly scoped interview that avoids non-public information.

The goal is not simply to find someone who once worked at a famous agency. The goal is to find a former decision-maker, reviewer, policy specialist, health economist, or reimbursement professional whose experience maps directly to your research question.

For pharmaceutical, biotechnology, medical-device, diagnostics, and HealthTech companies, reimbursement can determine whether regulatory approval translates into meaningful market access. A product may be authorized for sale but still face separate questions about coverage, coding, evidence requirements, payment levels, formulary placement, or HTA recommendations.

That is why reimbursement research often benefits from combining payer interviews with carefully selected former public-sector experts.

What Does Payer and Reimbursement Research Cover?

Healthcare payer research examines how public and private payers decide whether, when, and under what conditions healthcare products and services will be funded.

It can cover:

• coverage policy
• reimbursement pathways
• coding requirements
• payment mechanisms
• utilization management
• formulary decision-making
• evidence expectations
• health technology assessment
• pricing and contracting environments
• market-access barriers
• policy changes affecting adoption

In the United States, Medicare coverage itself illustrates why these questions need to be separated carefully. CMS states that a National Coverage Determination addresses whether an item or service is nationally covered, while the NCD itself does not determine the billing code or the payment amount. CMS also notes that Local Coverage Determinations may be developed by Medicare Administrative Contractors where no national decision exists or where national policy requires further local definition.

This separation matters for payer research. An expert who understands national coverage policy may not be the right person to explain HCPCS coding, provider economics, commercial formulary management, or local MAC behavior.

Regulatory Approval and Reimbursement Are Different Decisions

Regulatory expertise and reimbursement expertise overlap, but they are not interchangeable.

The FDA determines whether regulated medical products meet applicable regulatory requirements. CMS and other payer organizations make different decisions about coverage and payment. In the UK, NICE conducts health technology evaluations that can inform NHS access and funding decisions. NICE’s technology-appraisal manual was most recently updated in March 2026 and describes the methods and processes used to assess medicines and HealthTech.

Therefore, healthcare reimbursement market research should recruit experts based on the decision being investigated rather than the prestige of their previous employer.

A former FDA reviewer can be highly valuable when the question involves clinical evidence, endpoints, regulatory pathways, or how regulatory evidence may interact with downstream access requirements. But a former CMS policy specialist, HTA evaluator, payer medical director, or reimbursement strategist may be more relevant when the central question is coverage or payment.

Which Former Regulators Should You Recruit?

The phrase former regulators healthcare research often describes a broad sourcing requirement, but the brief should be considerably more precise.

Start by mapping the business question to the former role most likely to have encountered that issue firsthand.

CMS explicitly distinguishes national coverage, local coverage, coding, and payment, which is why treating “former CMS official” as a sufficient expert specification is usually too broad.

The same principle applies internationally. NICE evaluates medicines and HealthTech using defined health technology evaluation processes, while other institutions perform regulatory, procurement, commissioning, or payment functions.

Where Can You Find Former Regulators?

Former regulators are a relatively narrow respondent population. The strongest sourcing strategy normally combines custom expert recruitment, professional-network searches, public agency information, conferences, publications, and referrals.

Custom Expert Recruitment

For narrow regulatory and reimbursement briefs, custom sourcing can be more effective than relying entirely on an existing expert database.

The first approach can be particularly useful when the brief is narrow because its published process includes custom recruitment for specialized requirements, professional-profile verification, employer-history checks and configurable compliance screening.

LinkedIn and Professional Networks

LinkedIn works best when the search is based on former responsibilities rather than generic terms such as “healthcare regulator.”

Useful searches can combine:

• former agency + function
• agency + therapeutic area
• former title + reimbursement
• CMS + coverage policy
• NICE + health economics
• HTA + former assessor
• Medicare + medical director
• reimbursement policy + former government
• market access + former public sector

The profile should then be checked against employment dates, specific departments, responsibilities, publications, conference participation and other publicly verifiable evidence.

Agency, Conference, and Publication Research

Government biographies, archived leadership pages, committee materials, conference agendas, academic publications and policy reports can reveal people who worked directly on a relevant topic.

This is particularly useful when job titles are misleading. Two people may both have been “directors” at the same organization while having completely different exposure to reimbursement decisions.

How Should Former Regulators Be Screened?

Strong healthcare regulatory experts should be screened for relevance before their name reaches the client.

A practical screening process should confirm:

• Exact organization and unit: Where did the person actually work?
• Employment period: When did they join and leave?
• Decision exposure: Did they participate directly in the issue being researched?
• Therapeutic or technology relevance: Was their experience related to the product category?
• Geographic relevance: Which payer or regulatory environment did they work in?
• Current employment: Could their present role create a conflict?
• Post-employment restrictions: Are specific activities, representations or topics restricted?
• Confidentiality obligations: What information are they prohibited from discussing?
• Communication quality: Can they explain complex policy decisions clearly?

A CV alone does not establish subject-matter fit. Screening should distinguish between someone who observed a process and someone who actually worked on it.

What Compliance Rules Apply When Recruiting Former Regulators?

Former-government recruitment requires more than an NDA.

Understand Post-Employment Restrictions

In the United States, there is no single blanket “cooling-off period” that applies to every former federal employee and every activity.

For former FDA employees, for example, federal post-employment rules can include a permanent restriction on certain representational activity involving specific matters in which the person participated personally and substantially, a two-year restriction relating to certain matters under their official responsibility, and a one-year agency-contact restriction for qualifying senior employees. The exact restrictions depend on the individual’s former position, matter and proposed activity.

This distinction is important. A compliant research interview is not automatically prohibited simply because someone recently left government, but neither should a research company assume the interview is permissible without screening.

In the UK, former Crown servants can also be subject to Business Appointment Rules and individual conditions concerning lobbying, privileged information, former matters or interactions with government. Current government disclosures continue to show role-specific restrictions rather than one universal condition.

For high-risk or unclear engagements, legal or compliance counsel should determine whether the proposed scope is permissible.

Protect Confidential and Non-Public Information

The objective of an interview should be to capture expertise, judgment and interpretation based on permissible knowledge not confidential government information.

Researchers should explicitly tell experts not to disclose:

• confidential government information
• privileged documents
• non-public deliberations
• protected commercial information
• confidential information belonging to a former employer
• restricted information relating to specific pending matters

FDA’s ethics guidance specifically addresses post-employment restrictions and the handling of non-public government information, reinforcing why former officials should be screened before engagement.

Use NDAs as One Control, Not the Entire Compliance Process

An NDA protects the research engagement, but it does not override a former official’s statutory, contractual, professional or ethical obligations.

A stronger process combines:

• expert terms and conditions
• conflict-of-interest screening
• former-employer checks
• project-specific attestations
• restricted-topic screening
• an approved discussion guide
• a clear right for the expert to decline individual questions
• documented compliance records

The research team should also avoid framing questions in a way that invites disclosure about a particular confidential case.

How Much Should Former Regulators Be Paid?

Compensation should be based on fair market value for the individual’s expertise and the demands of the engagement.

There is no reliable universal hourly rate for a “former regulator.” Rates can vary substantially according to seniority, geography, specialization, scarcity, preparation time, project complexity and whether the work involves a single interview or continued advisory support.

Compensation should therefore be established before the interview and documented clearly.

For a straightforward qualitative call, consider:

• agreed interview duration
• expected preparation
• subject complexity
• scarcity of the expertise
• seniority
• geographic market
• urgency
• additional deliverables

Avoid artificially high compensation intended to encourage disclosure or influence the nature of an expert’s responses. Where the expert is also a healthcare professional, additional company policies or industry-specific fair-market-value requirements may need to be considered.

How Should Interviews Be Structured?

A former-regulator interview works best when it focuses on processes, decision criteria, evidence expectations and publicly discussable experience.

Begin broadly before testing specific hypotheses.

Useful questions include:

• What evidence tends to matter most in this type of coverage decision?
• Where do companies commonly misunderstand the reimbursement pathway?
• Which evidence gaps tend to create uncertainty?
• How should a company distinguish regulatory evidence from payer evidence?
• Which parts of the pathway are national, local or payer-specific?
• What changes in the policy environment should companies monitor?
• Where would you validate this interpretation using public guidance?

The last question is especially valuable because it helps the research team triangulate expert opinion against authoritative documentation.

Qualitative Interviews

One-to-one qualitative interviews are appropriate when the goal is exploratory reimbursement market intelligence.

They work well for:

• pathway mapping
• policy interpretation
• evidence-gap identification
• hypothesis testing
• identifying likely payer objections
• understanding decision processes

Ongoing Advisory Engagements

An advisory relationship may be appropriate when a company needs repeated input throughout evidence development, market-access planning or launch preparation.

However, ongoing engagements require additional discipline. Conflicts can change when an expert changes jobs or when the client’s project moves into a different policy area. Eligibility should therefore be reassessed periodically rather than assumed indefinitely.

How Do You Turn Interviews Into Reimbursement Market Intelligence?

The value of expert interviews comes from synthesis, not transcripts.

A strong research team converts individual observations into a structured evidence matrix.

For each important insight, record:

Issue → Expert interpretation → Supporting public evidence → Degree of agreement → Business implication → Remaining uncertainty → Recommended next step

For example:

A former CMS policy expert may explain why a specific evidence package could face a coverage challenge. The research team should then compare that interpretation with current CMS coverage criteria, existing NCDs or LCDs, relevant evidence-review guidance and interviews with other stakeholder types.

CMS states that national coverage analysis considers clinical experience together with medical, technical and scientific evidence. That makes evidence-quality questions particularly appropriate for expert interviews, while final conclusions should still be anchored to current policy and official documentation.

Triangulation also prevents one former official’s experience from being mistaken for universal policy.

Common Mistakes When Recruiting Former Regulators

Several mistakes repeatedly reduce the value of former-regulator research.

• Recruiting by logo instead of responsibility. A famous agency on a résumé does not guarantee relevant experience.
• Treating FDA approval and reimbursement as the same question. They are connected but involve different decision systems.
• Using vague screeners. “Do you understand Medicare?” is far less useful than verifying specific experience with NCDs, LCDs, coding, payment policy or evidence review.
• Skipping post-employment screening. Restrictions depend on the expert’s previous position and activities.
• Assuming an NDA solves every compliance issue. It does not authorize disclosure of protected information.
• Relying on one expert. Regulatory and reimbursement systems are complex. Important conclusions should be triangulated across expert interviews and public evidence.
• Asking for predictions instead of mechanisms. “Will CMS cover this?” is usually weaker than asking which evidence, criteria and process factors are likely to shape a coverage assessment.

A Practical Former-Regulator Recruitment Workflow

A repeatable process makes recruitment faster and safer.

Step 1: Define the decision. Specify whether the study concerns coverage, coding, payment, HTA, formulary access, evidence requirements or another issue.

Step 2: Build the ideal expert profile. Define former organization, department, seniority, dates, geography, product type and relevant decision exposure.

Step 3: Source beyond existing databases. Use custom recruitment, LinkedIn, publications, government biographies, conferences and referrals.

Step 4: Conduct expertise screening. Confirm that the candidate personally encountered the relevant subject rather than having adjacent experience.

Step 5: Conduct compliance screening. Check former-employer restrictions, current conflicts, post-employment rules and prohibited topics before the interview.

Step 6: Set scope and compensation. Define the interview duration, purpose, permitted topics, rate and confidentiality requirements.

Step 7: Interview and triangulate. Compare expert insights with other stakeholder interviews and current authoritative sources before using them in a strategic recommendation.

Frequently Asked Questions

Can a company recruit a former FDA employee for market research?
Potentially, yes. Former FDA employees are subject to post-employment restrictions that vary by their former responsibilities, seniority, subject matter and proposed activity. The engagement should therefore be screened rather than automatically approved or rejected.

Is a former FDA regulator always the best expert for reimbursement research?
No. FDA expertise is strongest for questions involving regulatory review and evidence requirements. For Medicare coverage, CMS or MAC experience may be more relevant. For UK HTA questions, former NICE or other relevant HTA professionals may provide a better fit. CMS and NICE maintain distinct coverage and health-technology-evaluation processes.

Should research focus only on former regulators?
Usually not. Strong payer studies can combine former public officials with current or former payer decision-makers, market-access professionals, health economists, clinicians and other stakeholders. Each group reveals a different part of the reimbursement pathway.

Should the expert receive the discussion guide before the call?
For sensitive regulatory studies, sharing at least the topic areas or high-level agenda in advance can help identify restricted questions before the interview begins.

How many former regulators should be interviewed?
There is no universal number. Sample size should depend on the number of jurisdictions, stakeholder groups, research questions and the degree of saturation required. For strategic decisions, triangulation is generally more defensible than treating a single interview as conclusive.

Need the right former regulator, not just another name in a database?

Nexus Expert Research can custom-source and screen payer, reimbursement, regulatory, and market-access experts around the exact brief your decision requires.